Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Consolidated Nine Months - Aurobindo Pharma

Aurobindo Pharma

BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 13, 16:00
449.20
0.6 (0.13%)
VOLUME 89,216
LIVE
NSE
Dec 13, 15:59
449.35
0.6 (0.13%)
VOLUME 2,964,208
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Consolidated Nine Months of Aurobindo Pharma

------------------- in Rs. Cr. -------------------
Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
Net Sales/Income from operations 14,023.94 12,244.24 11,262.66 10,035.88 8,899.26
Other Operating Income 247.40 206.51 185.57 173.42 59.19
Total Income From Operations 14,271.34 12,450.75 11,448.23 10,209.30 8,958.45
EXPENDITURE
Consumption of Raw Materials 5,453.70 4,201.58 3,905.50 3,593.26 3,090.46
Purchase of Traded Goods 1,430.99 1,139.15 1,210.85 1,036.95 1,375.70
Increase/Decrease in Stocks -544.67 -257.46 -184.90 -94.01 -282.30
Power & Fuel -- -- -- -- --
Employees Cost 1,871.41 1,549.57 1,304.30 1,135.81 1,013.35
Depreciation 481.33 401.34 327.58 280.97 247.94
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 3,225.75 2,834.26 2,499.44 2,215.49 1,853.71
P/L Before Other Inc., Int., Excpt. Items & Tax 2,352.83 2,582.31 2,385.46 2,040.83 1,659.59
Other Income 83.39 58.15 32.09 49.10 74.02
P/L Before Int., Excpt. Items & Tax 2,436.22 2,640.46 2,417.55 2,089.93 1,733.61
Interest 112.58 52.99 9.42 108.09 122.51
P/L Before Exceptional Items & Tax 2,323.64 2,587.47 2,408.13 1,981.84 1,611.10
Exceptional Items -51.88 -- -- -- --
P/L Before Tax 2,271.76 2,587.47 2,408.13 1,981.84 1,611.10
Tax 495.74 695.89 642.50 514.35 443.20
P/L After Tax from Ordinary Activities 1,776.02 1,891.58 1,765.63 1,467.49 1,167.90
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 1,776.02 1,891.58 1,765.63 1,467.49 1,167.90
Minority Interest 0.07 0.51 0.24 1.24 4.06
Share Of P/L Of Associates 3.22 2.58 3.34 1.58 --
Net P/L After M.I & Associates 1,779.31 1,894.67 1,769.21 1,470.31 1,171.96
Equity Share Capital 58.59 58.59 58.52 58.40 29.15
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 30.37 32.34 30.23 25.18 40.21
Diluted EPS 30.37 32.34 30.23 25.16 40.16
EPS After Extra Ordinary
Basic EPS 30.37 32.34 30.23 25.18 40.21
Diluted EPS 30.37 32.34 30.23 25.16 40.16
Public Share Holding
No Of Shares (Crores) -- -- -- -- 13.39
Share Holding (%) -- -- -- -- 45.94
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- 1.35
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- 8.56
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- 4.63
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- 14.41
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- 91.44
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- 49.43
Notes
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for aurobindopharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.